PCV61 THE COST-EFFECTIVENESS OF EXTENDED VENOUS THROMBOEMBOLISM PROPHYLAXIS WITH ENOXAPARIN VERSUS SHORT-TERM PROPHYLAXIS AFTER ELECTIVE HIP REPLACEMENT IN POLAND

The Cost ◽

Short Term Prophylaxis

The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

DARU Journal of Pharmaceutical Sciences ◽

10.1007/s40199-019-00292-1 ◽

2019 ◽

Vol 27 (2) ◽

pp. 627-634

Author(s):

Mohammadreza Amirsadri ◽

Sarah Mousavi ◽

Ali Karimipour

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Medical Inpatients ◽

The Cost

The Cost-Effectiveness of Current Practice of Venous Thromboembolism Prophylaxis as Compared to No Prophylaxis or Pharmaceuticals Only Prophylaxis

10.5204/thesis.eprints.120279 ◽

2018 ◽

Author(s):

Yupin Crawford

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Current Practice ◽

The Cost

Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement

Phlebology The Journal of Venous Disease ◽

10.1007/bf02638605 ◽

2002 ◽

Vol 17 (3-4) ◽

pp. 126-133 ◽

Cited By ~ 2

Author(s):

J. A. Caprini ◽

J. I. Arcelus ◽

J. C. Kudrna ◽

L. R. Sehgal ◽

M. Oyslender ◽

...

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Total Hip Replacement ◽

Hip Replacement ◽

Total Hip ◽

A decision-tree model to estimate the impact on cost-effectiveness of a venous thromboembolism prophylaxis guideline

BMJ Quality & Safety ◽

10.1136/qshc.2007.023135 ◽

2009 ◽

Vol 18 (4) ◽

pp. 309-313 ◽

Cited By ~ 5

Author(s):

A Ferrando ◽

E Pagano ◽

L Scaglione ◽

M Petrinco ◽

D Gregori ◽

...

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Decision Tree ◽

Decision Tree Model ◽

Tree Model ◽

Prophylaxis Guideline ◽

The Impact

Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden

The European Journal of Health Economics ◽

10.1007/s10198-003-0175-4 ◽

2003 ◽

Vol 4 (4) ◽

pp. 254-262 ◽

Cited By ~ 15

Author(s):

Jonas Lundkvist ◽

David Bergqvist ◽

Bengt J�nsson

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years

Current Medical Research and Opinion ◽

10.1185/03007990802443255 ◽

2008 ◽

Vol 24 (10) ◽

pp. 2993-3006 ◽

Cited By ~ 13

Author(s):

S.E. Wolowacz ◽

N. Hess ◽

V.K. Brennan ◽

B.U. Monz ◽

J.M. Plumb

Keyword(s):

Health Economic ◽

Venous Thromboembolism ◽

Cost Effectiveness ◽

Knee Replacement ◽

Economic Modelling ◽

Knee Replacement Surgery ◽

Replacement Surgery ◽

Health Economic Modelling

PCV85 - COST-EFFECTIVENESS OF BETRIXABAN COMPARED WITH ENOXAPARIN OR FONDAPARINUX FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HOSPITALISED ACUTE MEDICALLY ILL PATIENTS IN THE UNITED KINGDOM

Value in Health ◽

10.1016/j.jval.2018.09.631 ◽

2018 ◽

Vol 21 ◽

pp. S106-S107

Author(s):

V. Laskier ◽

H. Guy ◽

M. Fisher ◽

W.R. Neuman ◽

I. Bucior ◽

...

Keyword(s):

United Kingdom ◽

Venous Thromboembolism ◽

Cost Effectiveness ◽

Medically Ill ◽

The United Kingdom ◽

Medically Ill Patients

Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in elective hip replacement surgery

Blood Coagulation & Fibrinolysis ◽

10.1097/00001721-200410000-00002 ◽

2004 ◽

Vol 15 (7) ◽

pp. 539-543

Author(s):

William J Spruill ◽

William E Wade ◽

Ryan B Leslie

Keyword(s):

Venous Thromboembolism ◽

Cost Analysis ◽

Hip Replacement ◽

Replacement Surgery ◽

Hip Replacement Surgery ◽

Cost-Effectiveness of Extended Duration Venous Thromboembolism Prophylaxis in High Risk Urological Oncology Surgical Patients

Urology Practice ◽

10.1016/j.urpr.2015.08.004 ◽

2016 ◽

Vol 3 (4) ◽

pp. 262-269 ◽

Cited By ~ 2

Author(s):

Janet E. Baack Kukreja ◽

Helen R. Levey ◽

Ahmed Ghazi ◽

Hani Rashid ◽

Guan Wu ◽

...

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

High Risk ◽

Surgical Patients ◽

Urological Oncology ◽

Extended Duration

Cost–effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in hip surgery patients

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.6.2.171 ◽

2006 ◽

Vol 6 (2) ◽

pp. 171-180 ◽

Cited By ~ 4

Author(s):

Matthias Bischof ◽

Jörg D Leuppi ◽

Pedram Sendi

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Hip Surgery ◽